IMMT and cancer: Proof of concept for the therapeutic targeting of trafficking machinery motor proteins in cancer has been demonstrated with the discovery of the aminothiazole dynarrestin, a novel inhibitor of dynein that inhibited the proliferation of oesophageal squamous cell carcinoma cells [214].